HPQ Silicon Starts Production of HPQ ENDURA+ 18650 and 21700 Cells Completion of Technical Datasheets in Collaboration with Cell Manufacture GlobeNewswire August 14, 2025 MONTREAL, Aug. 14, 2025 (GLOBE NEWSWIRE) — HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company specializing in innovation in advanced materials and critical […]

Chicago Atlantic BDC, Inc. Reports Second Quarter 2025 Financial Results GlobeNewswire August 14, 2025 NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) — Chicago Atlantic BDC, Inc. (“LIEN” or the “Company”) (NASDAQ: LIEN), a specialty finance company that has elected to be regulated as a business development company, today announced its financial results for the second

Aduro Clean Technologies Provides Update on NGP Pilot Plant Progress GlobeNewswire August 14, 2025 LONDON, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company“) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and

Oroco Congratulates Hudbay Minerals Inc. GlobeNewswire August 14, 2025 VANCOUVER, Canada, Aug. 14, 2025 (GLOBE NEWSWIRE) — Vancouver, CANADA. – August 14th, 2025 – Oroco Resource Corp. (TSX-V: OCO; OTCQB: ORRCF) (“Oroco” or “the Company“) extends its congratulations to Hudbay Minerals Inc. (“Hudbay“) for its agreement with Mitsubishi Corporation (“Mitsubishi“) announced on August 13th 2025,

SRx Health Solutions Announces the Cancellation of Approximately 18.8 Million Shares of its Capital Stock The Company intends to explore all available legal remedies against former officers of SRx Canada GlobeNewswire August 14, 2025 TAMPA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health

Traws Pharma Reports Second Quarter 2025 Results and Business Highlights GlobeNewswire August 14, 2025 Advancing novel programs for respiratory viruses that pose pandemic threats or risk of serious illness, including SARS CoV2 (ratutrelvir) and influenza (Tivoxavir marboxil, TXM) Prioritization of ratutrelvir, a ritonavir-free, protease inhibitor regimen in development for Acute and Long COVID, reflects the

SEED Therapeutics Named Finalist for 2025 Prix Galien USA “Best Start-Up” Award GlobeNewswire August 14, 2025 Nomination recognizes SEED's pioneering work inmolecular glue development in targeted protein degradationto address high unmet medical needs Follows recent FDA IND clearance for SEED'slead asset RBM39 degrader ST-01156 KING OF PRUSSIA, Pa., Aug. 14, 2025 (GLOBE NEWSWIRE) — SEED

Denovo Biopharma LLC to Participate in Upcoming Investor Events GlobeNewswire August 14, 2025 SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) — Denovo Biopharma LLC, a pioneer in applying precision medicine to development of innovative drugs, today announced that company management will participate in upcoming August and September investor events. The presentations will highlight Denovo's lead

Unicycive Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update GlobeNewswire August 14, 2025 – Type A Meeting requested with U.S. Food and Drug Administration (FDA) for resolution of the Complete Response Letter (CRL) for oxylanthanum carbonate (OLC) – OLC pivotal study data, published in the Clinical Journal of the American Society of

atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates GlobeNewswire August 14, 2025 Planned strategic combination with Beckley Psytech expected to solidify position as global leader in transformative, psychedelic-based mental health therapies with a short time in-clinic Reported positive topline data from the core, blinded stage of the Phase 2b clinical